Diana Brainard Allovir, Inc. (ALVR) insider trading activity

Diana Brainard is Chief Executive Officer of Allovir, Inc.. Currently has a direct ownership of 723,363 shares of ALVR, which is worth approximately $339,980. The most recent transaction as insider was on Nov 19, 2024, when has been sold 8,706 shares (Common Stock) at a price of $0.55 per share, resulting in proceeds of $4,788. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 723K

4.05% 3M change

17.32% 12M change

Total Value Held $339,980

Diana Brainard Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 19 2024	SELL Open market or private sale	$4,788 $0.55 p/Share	8,706 Reduced 1.19%	723,363 Common Stock
Nov 05 2024	SELL Open market or private sale	$9,123 $0.86 p/Share	10,609 Reduced 1.43%	732,069 Common Stock
Oct 21 2024	SELL Open market or private sale	$7,606 $0.78 p/Share	9,752 Reduced 1.3%	742,678 Common Stock
Oct 03 2024	SELL Open market or private sale	$1,209 $0.81 p/Share	1,493 Reduced 0.2%	752,430 Common Stock
Aug 20 2024	SELL Open market or private sale	$3,988 $0.74 p/Share	5,390 Reduced 0.71%	753,923 Common Stock
Aug 19 2024	SELL Open market or private sale	$2,349 $0.76 p/Share	3,091 Reduced 0.41%	759,313 Common Stock
Aug 05 2024	SELL Open market or private sale	$7,918 $0.73 p/Share	10,847 Reduced 1.4%	762,404 Common Stock
Jul 19 2024	SELL Open market or private sale	$7,298 $0.75 p/Share	9,731 Reduced 1.24%	773,251 Common Stock
Jul 02 2024	SELL Open market or private sale	$1,072 $0.72 p/Share	1,489 Reduced 0.19%	782,982 Common Stock
May 21 2024	SELL Open market or private sale	$4,067 $0.79 p/Share	5,149 Reduced 0.65%	784,471 Common Stock
May 17 2024	SELL Open market or private sale	$2,306 $0.75 p/Share	3,075 Reduced 0.39%	789,620 Common Stock
May 03 2024	SELL Open market or private sale	$8,192 $0.8 p/Share	10,240 Reduced 1.28%	792,695 Common Stock
Apr 19 2024	SELL Open market or private sale	$7,200 $0.75 p/Share	9,601 Reduced 1.18%	802,935 Common Stock
Apr 02 2024	SELL Open market or private sale	$1,180 $0.77 p/Share	1,533 Reduced 0.19%	812,536 Common Stock
Feb 21 2024	SELL Open market or private sale	$3,660 $0.71 p/Share	5,155 Reduced 0.63%	814,069 Common Stock
Feb 20 2024	SELL Open market or private sale	$2,167 $0.7 p/Share	3,097 Reduced 0.38%	819,224 Common Stock
Feb 05 2024	SELL Open market or private sale	$27,752 $0.67 p/Share	41,421 Reduced 4.8%	822,321 Common Stock
Jan 23 2024	SELL Open market or private sale	$6,365 $0.67 p/Share	9,500 Reduced 1.09%	863,742 Common Stock
Jan 04 2024	SELL Open market or private sale	$1,064 $0.64 p/Share	1,664 Reduced 0.19%	873,242 Common Stock
Nov 20 2023	SELL Open market or private sale	$7,405 $1.69 p/Share	4,382 Reduced 0.5%	874,906 Common Stock
Nov 17 2023	SELL Open market or private sale	$4,383 $1.63 p/Share	2,689 Reduced 0.3%	879,288 Common Stock
Oct 19 2023	SELL Open market or private sale	$13,557 $1.58 p/Share	8,581 Reduced 0.96%	881,977 Common Stock
Oct 03 2023	SELL Open market or private sale	$2,623 $1.98 p/Share	1,325 Reduced 0.15%	890,558 Common Stock
Aug 18 2023	SELL Open market or private sale	$11,313 $2.79 p/Share	4,055 Reduced 0.45%	891,883 Common Stock
Aug 17 2023	SELL Open market or private sale	$28,402 $2.5 p/Share	11,361 Reduced 1.25%	895,938 Common Stock

Also insider at

NKTR

NEKTAR THERAPEUTICS Healthcare

Director

Diana Brainard

Chief Executive Officer

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALVR shares.

Notify only if

Value

Insider Trading

Get notified when an Allovir, Inc. insider buys or sells ALVR shares.

Notify only if

Operation

Value

Type

News

Receive news related to Allovir, Inc.

Track Activities on ALVR

Account